Genomatica To Focus On Development Of Biobased Nylon Intermediates

Lynn Bergeson
Bergeson & Campbell, P.C.
Contact
LinkedIn
Facebook
X
Send
Embed

On August 5, 2014, Genomatica announced that it will be focusing on developing complete process technologies for the biobased production of major nylon intermediates -- including hexamethylenediamine, caprolactam, and adipic acid (HMD, CPL, and ADA). A copy of Genomatica's press release on this announcement is available online.

Send Print Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Bergeson & Campbell, P.C. | Attorney Advertising

Written by:

Bergeson & Campbell, P.C.
Bergeson & Campbell, P.C.
Contact
more
less

Bergeson & Campbell, P.C. on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign Up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide